Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, signaling a minor update to the page's version or underlying content.SummaryDifference0.1%

- Check23 days agoChange DetectedNo textual changes were captured for this page in the provided data.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study record page was updated to Revision: v3.6.4, indicating a new release of the page. This update appears to be internal maintenance rather than a modification to study content.SummaryDifference0.0%

- Check52 days agoChange DetectedA revision label on the study page was updated from v3.6.2 to v3.6.3, indicating an administrative update to the ClinicalTrials.gov page. It does not alter the study details, enrollment, or eligibility.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays revision v3.6.2, replacing the previous v3.6.0. This indicates a page-build update rather than a change to study details.SummaryDifference0.0%

- Check73 days agoChange DetectedNew navigation and help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status now indicates no longer looking for participants. A formatting adjustment for Intervention/Treatment and an update to the page revision (v3.6.0) are also included.SummaryDifference0.4%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.